Ladiratuzumab Biosimilar (Anti-LIV-1 / SLC39A6 Reference Antibody）

• Catalog Number: orb2703970
• Category: Antibodies
• Description: Ladiratuzumab (hLIV22) is an anti-LIV-1/ZIP6 humanized monoclonal antibody. Ladiratuzumab, conjugated with the microtubule disrupting agent, MMAE (HY-15162) to compose SGN-LIV1A, an antibody-drug conjugate (ADC). Ladiratuzumab can be used for research of breast cancer.
• Target: Ladiratuzumab Biosimilar（Anti-LIV-1 / SLC39A6 Reference Antibody）
• Clonality: Monoclonal
• Conjugation: Unconjugated
• Antibody Type: Biosimilar Antibody
• CAS Number: 1629760-28-6
• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Note: For research use only
• Expiration Date: 12 months from date of receipt.